Today, India Pharma Inc stands poised on the cusp of a transformation. The right measures could catapult it to further glory but missteps could also lead to the loss of its growth momentum.
Therefore, Chandigarh Pharma Summit’s key objective is to highlight the opportunities and benefits that this UT and capital city offers to aid India’s ambitions to be a pharma powerhouse. Its proximity to other prominent pharma hubs like Baddi, Nalagarh, Paonta Sahib, Solan in Himachal Pradesh; Punjab and Haryana, makes it a perfect destination for industry stakeholders to come together and ponder upon issues that need attention.
Leaders from the industry will brainstorm and share insights on strategies and measures needed to mitigate risks and challenges that prevent Chandigarh from achieving its true potential.
Deputy Drugs Controller, India, Central Drugs Standard Control Organization (CDSCO)
Assistant State Drugs Controller, Haryana, Food & Drugs Administration (FDA)
Director - GxP & Regulatory, GxP Pharmatraine Pvt Ltd
CEO, Valence Labs
CQA Head, Morepen Laboratories Ltd
Executive Sr Manager - Quality Control, Indoco Remedies Ltd
Consultant, Pharma Quality, Compliance & Manufacturing process, Aqex Pharma Solutions Pvt Ltd
Manager-Business Development, Ami Polymer Pvt Ltd
Head, Market Development & Marketing, SCIEX
Business Development Executive, Omega Scientific Instruments
Express Pharma, first published as Express Pharma Pulse in 1994, is today India’s leading business fortnightly for the pharmaceutical industry. With the patronage of its readers, Express Pharma has grown to become the No.1 Business News Magazine for the pharmaceutical industry. The editorial contents include: news, views, analysis and interviews, under four main segments: Market (The business of pharmaceuticals), Management (Insight for managing pharma), Research (Expertise for drug development) and Pharma Life (HR issues with a pharma focus). Besides this, we bring out periodic specials like the quarterly Pharma Technology Review, Packaging Special and LABNEXT.